Government on vaccination campaign in India

As India prepares for the vaccination campaign, around 100 people are expected to receive the anti-COVID-19 injections at each site per day, the government said.

Under the standard operating procedure (SOP) issued by the health ministry for all states and territories in the union, more than 100 people per day should be vaccinated at one site, and with sufficient resources, up to 200 can be vaccinated people reported. India today.

He also indicated that if in any case, more than 200 people are being vaccinated in one session, then a full team of 5 separate people should be deployed (one vaccination officer and 4 vaccination officers).

The vaccination center is expected to have three rooms or areas, including the waiting room, the vaccination room, and the observation room.

The Health Ministry has planned to vaccinate healthcare workers first, including frontline workers and those over 50. Following this, people under the age of 50 who have a chronic critical illness will be vaccinated. Based on the voter list prepared in the Lok Sabha and the assembly elections, people over 50 will be identified.

Subsequently, the entire population will be vaccinated, provided that the COVID-19 vaccine is ready for public use, depending on the spread and availability of this disease.

“Beneficiaries will be tracked through a digital platform called Co-WIN. All information on this platform will be updated in real time,” the draft SOP said.

Meanwhile, the government has lined up cold storage facilities with temperatures between 2 and 8 degrees Celsius (36 to 48 degrees Fahrenheit), said VK Paul, who heads the COVID-19 vaccine administration expert group.

Paul said these preparations meet the requirements of what he said were the four emerging candidates in the race for the Indian vaccine.

“The four that I can see, including Serum, Bharat, Zydus and Sputnik, need a normal cold chain. I don’t see any problem for these vaccines,” said VK Paul.

The Serum Institute of India, the world’s largest vaccine manufacturer, is already mass-producing and stocking AstraZeneca’s Covishield injection, while Indian biotech players Bharat Biotech and Zydus Cadila are developing their own candidate vaccines.

Also read: Uttar Pradesh Government Moves Higher Court Against Higher Court Order Releasing Dr. Kafeel Khan